This is the authors' abstract. We don't add key points for this paper.
// Jun Zhang 1 , Xue-Jiao Wang 1 , Xin Liu 1 , Yi Huan 2 , Miao-Miao Yang 2 , Zhu-Fang Shen 2 , Wen-Qing Jia 1 , Zhi Jing 1 , Shu-Qing Wang 1 , Wei-Ren Xu 3 , Xian-Chao Cheng 1 , Run-Ling Wang 1 1 Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China 2 Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China 3 Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China Correspondence to: Xian-Chao Cheng, email: chengxianchao@aliyun.com Run-Ling Wang, email: wangrunling@tmu.edu.cn Keywords: PPARs, Type 2 diabetes mellitus, bioisosterism, docking analysis, molecular dynamic simulations Received: December 28, 2016 Accepted: January 25, 2017 Published: February 08, 2017 ABSTRACT Peroxisome proliferators-activated receptors (PPARα, γ and δ) are potentially effective targets for Type 2 diabetes mellitus therapy. The severe effects of known glitazones and the successfully approved agents (saroglitazar and lobeglitazone) motivated us to study novelly potent PPARs drugs with improved safety profile. In this work, we received 15 carboxylic acids based on the combination principle to integrate the polar head of bezafibrate with the hydrophobic tail of pioglitazone. Another 12 tetrazoles based on the bioisosterism principle were obtained accordingly. Furthermore, in vitro PPARs transactivation assays on these 3- or 4-alkoxy substituted phenoxy derivatives afforded six compounds. Interactions and binding stability from the docking analysis and 20 ns molecular dynamic simulations confirmed the representative compounds to be suitable and plausible for PPARs pockets. The above-mentioned results demonstrated that the compounds may be used as reference for further optimization for enhanced PPARs activities and wide safety range.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: